AxoGen Operating Margin 2010-2025 | AXGN
Current and historical operating margin for AxoGen (AXGN) over the last 10 years. The current operating profit margin for AxoGen as of June 30, 2025 is -2.29%.
| AxoGen Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.20B | $0.00B | 0.98% |
| 2025-03-31 | $0.20B | 0 | 0.00% |
| 2024-12-31 | $0.19B | $0.00B | -1.60% |
| 2024-09-30 | $0.18B | $-0.01B | -4.42% |
| 2024-06-30 | $0.17B | $-0.01B | -6.94% |
| 2024-03-31 | $0.16B | $-0.02B | -11.66% |
| 2023-12-31 | $0.16B | $-0.02B | -13.21% |
| 2023-09-30 | $0.15B | $-0.02B | -15.79% |
| 2023-06-30 | $0.15B | $-0.03B | -16.89% |
| 2023-03-31 | $0.14B | $-0.03B | -18.06% |
| 2022-12-31 | $0.14B | $-0.03B | -21.74% |
| 2022-09-30 | $0.13B | $-0.03B | -21.64% |
| 2022-06-30 | $0.13B | $-0.03B | -24.22% |
| 2022-03-31 | $0.13B | $-0.03B | -23.44% |
| 2021-12-31 | $0.13B | $-0.03B | -19.53% |
| 2021-09-30 | $0.13B | $-0.03B | -19.53% |
| 2021-06-30 | $0.13B | $-0.02B | -14.62% |
| 2021-03-31 | $0.12B | $-0.02B | -16.95% |
| 2020-12-31 | $0.11B | $-0.02B | -20.72% |
| 2020-09-30 | $0.11B | $-0.03B | -23.36% |
| 2020-06-30 | $0.10B | $-0.03B | -29.13% |
| 2020-03-31 | $0.11B | $-0.03B | -27.78% |
| 2019-12-31 | $0.11B | $-0.03B | -28.97% |
| 2019-09-30 | $0.10B | $-0.03B | -29.41% |
| 2019-06-30 | $0.10B | $-0.03B | -30.21% |
| 2019-03-31 | $0.09B | $-0.03B | -28.89% |
| 2018-12-31 | $0.08B | $-0.02B | -25.00% |
| 2018-09-30 | $0.08B | $-0.02B | -21.79% |
| 2018-06-30 | $0.07B | $-0.01B | -18.31% |
| 2018-03-31 | $0.07B | $-0.01B | -13.85% |
| 2017-12-31 | $0.06B | $-0.01B | -11.67% |
| 2017-09-30 | $0.05B | $-0.01B | -14.81% |
| 2017-06-30 | $0.05B | $-0.01B | -16.33% |
| 2017-03-31 | $0.04B | $-0.01B | -20.45% |
| 2016-12-31 | $0.04B | $-0.01B | -22.50% |
| 2016-09-30 | $0.04B | $-0.01B | -24.32% |
| 2016-06-30 | $0.03B | $-0.01B | -29.41% |
| 2016-03-31 | $0.03B | $-0.01B | -33.33% |
| 2015-12-31 | $0.03B | $-0.01B | -37.04% |
| 2015-09-30 | $0.02B | $-0.01B | -41.67% |
| 2015-06-30 | $0.02B | $-0.01B | -47.62% |
| 2015-03-31 | $0.02B | $-0.01B | -52.63% |
| 2014-12-31 | $0.02B | $-0.01B | -58.82% |
| 2014-09-30 | $0.02B | $-0.01B | -66.67% |
| 2014-06-30 | $0.01B | $-0.01B | -76.92% |
| 2014-03-31 | $0.01B | $-0.01B | -83.33% |
| 2013-12-31 | $0.01B | $-0.01B | -81.82% |
| 2013-09-30 | $0.01B | $-0.01B | -80.00% |
| 2013-06-30 | $0.01B | $-0.01B | -88.89% |
| 2013-03-31 | $0.01B | $-0.01B | -100.00% |
| 2012-12-31 | $0.01B | $-0.01B | -100.00% |
| 2012-09-30 | $0.01B | $-0.01B | -114.29% |
| 2012-06-30 | $0.01B | $-0.01B | -150.00% |
| 2012-03-31 | $0.01B | $-0.01B | -160.00% |
| 2011-12-31 | $0.00B | $-0.01B | -175.00% |
| 2011-09-30 | $0.01B | $-0.01B | -160.00% |
| 2011-06-30 | $0.01B | $-0.01B | -120.00% |
| 2011-03-31 | $0.00B | $-0.01B | -125.00% |
| 2010-12-31 | $0.00B | $0.00B | -133.33% |
| 2010-09-30 | $0.03B | $0.02B | 60.00% |
| 2010-06-30 | $0.02B | $0.02B | 66.67% |
| 2010-03-31 | $0.03B | $0.02B | 64.00% |
| 2009-12-31 | $0.03B | $0.02B | 64.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.640B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $173.973B | 21.05 |
| Intuitive Surgical (ISRG) | United States | $168.513B | 69.85 |
| IDEXX Laboratories (IDXX) | United States | $52.648B | 54.79 |
| Edwards Lifesciences (EW) | United States | $45.999B | 30.49 |
| Alcon (ALC) | Switzerland | $42.296B | 28.58 |
| DexCom (DXCM) | United States | $30.925B | 46.39 |
| IQVIA Holdings (IQV) | United States | $30.576B | 17.28 |
| Mettler-Toledo (MTD) | United States | $25.872B | 30.71 |
| STERIS (STE) | Ireland | $23.889B | 25.46 |
| Waters (WAT) | United States | $16.738B | 22.99 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.603B | 0.00 |
| Hologic (HOLX) | United States | $15.138B | 16.40 |
| Penumbra (PEN) | United States | $9.379B | 68.52 |
| Sysmex ADR (SSMXY) | Japan | $8.712B | 27.68 |
| Globus Medical (GMED) | United States | $7.940B | 18.27 |
| Masimo (MASI) | United States | $7.862B | 26.46 |
| Teleflex (TFX) | United States | $5.233B | 8.45 |
| Glaukos (GKOS) | United States | $4.855B | 0.00 |
| TransMedics (TMDX) | United States | $3.903B | 59.33 |
| Integer Holdings (ITGR) | United States | $3.729B | 18.61 |
| LivaNova (LIVN) | United Kingdom | $2.667B | 15.26 |
| Alphatec Holdings (ATEC) | United States | $2.215B | 0.00 |
| Veracyte (VCYT) | United States | $2.143B | 29.75 |
| PROCEPT BioRobotics (PRCT) | United States | $2.125B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.981B | 23.65 |
| Elekta AB (EKTAY) | Sweden | $1.881B | 16.91 |
| Artivion (AORT) | United States | $1.749B | 97.50 |
| Integra LifeSciences Holdings (IART) | United States | $1.010B | 5.79 |
| OPKO Health (OPK) | United States | $0.992B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| IRadimed (IRMD) | United States | $0.890B | 43.17 |
| Tandem Diabetes Care (TNDM) | United States | $0.759B | 0.00 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.641B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.535B | 4.30 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.502B | 8.87 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.474B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.405B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.386B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.354B | 8.99 |
| Delcath Systems (DCTH) | United States | $0.350B | 83.42 |
| AngioDynamics (ANGO) | United States | $0.346B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.303B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| RxSight (RXST) | United States | $0.292B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.288B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.274B | 18.89 |
| Neuronetics (STIM) | United States | $0.273B | 0.00 |
| 908 Devices (MASS) | United States | $0.227B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.193B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.169B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.117B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.112B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| InspireMD (NSPR) | United States | $0.101B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.089B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.015B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.008B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.74 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |